As of 2025-12-19, the Relative Valuation of Eupraxia Pharmaceuticals Inc (EPRX.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 8.55 CAD, the upside of Eupraxia Pharmaceuticals Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-12-12 | -14.88 |
| 2025-12-11 | -15.28 |
| 2025-12-10 | -14.98 |
| 2025-12-09 | -14.28 |
| 2025-12-08 | -14.28 |
| 2025-12-05 | -14.73 |
| 2025-12-04 | -13.90 |
| 2025-12-03 | -14.23 |
| 2025-12-02 | -14.26 |
| 2025-12-01 | -14.47 |
| 2025-11-28 | -15.05 |
| 2025-11-27 | -15.17 |
| 2025-11-26 | -15.04 |
| 2025-11-25 | -15.04 |
| 2025-11-24 | -15.33 |
| 2025-11-21 | -15.31 |
| 2025-11-20 | -15.31 |
| 2025-11-19 | -15.16 |
| 2025-11-18 | -15.52 |
| 2025-11-17 | -16.19 |
| 2025-11-14 | -16.04 |
| 2025-11-13 | -15.14 |
| 2025-11-12 | -16.12 |
| 2025-11-11 | -16.00 |
| 2025-11-10 | -14.97 |
| 2025-11-07 | -13.24 |
| 2025-11-06 | -13.73 |
| 2025-11-05 | -13.78 |
| 2025-11-04 | -13.36 |
| 2025-11-03 | -13.79 |
| 2025-10-31 | -13.79 |
| 2025-10-30 | -12.93 |
| 2025-10-29 | -13.10 |
| 2025-10-28 | -13.50 |
| 2025-10-27 | -13.05 |
| 2025-10-24 | -13.19 |
| 2025-10-23 | -13.59 |
| 2025-10-22 | -13.17 |
| 2025-10-21 | -13.28 |
| 2025-10-20 | -14.23 |
| 2025-10-17 | -14.00 |
| 2025-10-16 | -14.07 |
| 2025-10-15 | -14.62 |
| 2025-10-14 | -14.79 |
| 2025-10-10 | -14.48 |
| 2025-10-09 | -14.83 |
| 2025-10-08 | -14.88 |
| 2025-10-07 | -14.48 |
| 2025-10-06 | -14.33 |
| 2025-10-03 | -14.02 |